Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2022-12-19 Transaction in Own Shar…
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
2022 12 16 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between December 12, 2022, and December 16, 2022. It provides transaction summaries and detailed daily transaction logs. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2022-12-19 Italian
Allegato 3F - Novembre
Director's Dealing Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI" / "MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUER'S SECURITIES". It details transactions (purchases 'A') in the issuer's shares (PHILOGEN S.p.A.) during November 2022. This structure is characteristic of mandatory regulatory filings reporting insider or director share dealings. Among the provided codes, 'DIRS' (Director's Dealing) is the most specific match for a report detailing personal share transactions by company directors and executives, even if the filing itself is a standardized schema rather than a narrative report.
2022-12-12 Italian
2022 12 09 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between December 5, 2022, and December 9, 2022, including daily transaction logs and total consideration. This activity directly relates to the company managing its own outstanding shares, which falls under the definition of 'Transaction in Own Shares' (POS). The document is a direct report of the transaction activity, not merely an announcement of a report's publication.
2022-12-12 Italian
2022 12 02 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 99% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between November 28, 2022, and December 2, 2022, including daily transaction tables. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2022-12-05 Italian
2022 11 25 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 98% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between November 21, 2022, and November 25, 2022. This explicitly concerns the company's transaction in its own shares (share repurchase). This directly corresponds to the definition for 'Transaction in Own Shares' (Code: POS). Although it is a report of transactions, it is not a general regulatory filing (RNS) or a report publication announcement (RPA) because it contains the substantive data itself, not just an announcement that a report is available. It is not a Director's Dealing (DIRS) as it concerns the company itself buying its own stock, not an executive's personal trade.
2022-11-28 Italian
2022 11 18 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between November 14, 2022, and November 18, 2022, including daily transaction logs and total consideration. This activity directly relates to the company managing its own equity structure by repurchasing shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K).
2022-11-21 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.